Effectiveness and Efficiency of Selective vs Universal Screening for Chlamydial Infection in Sexually Active Young Women

Archives of Internal Medicine

Volumn 152, Issue 9, 1992, Pages 1837-1844

  Sellors, John W ^a   Pickard, Laura ^a   Gafni, Amiram ^a,c   Goldsmith, Charlie H ^a   Jang, Dan ^a   Mahony, James B ^a   Chernesky, Max A ^a,b  

^a Hamilton Wentworth Department of Public Health Services ^*  (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CASE FINDING; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CONFERENCE PAPER; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; ENZYME IMMUNOASSAY; FEMALE; HUMAN; MASS SCREENING; PATIENT SELECTION; PELVIC INFLAMMATORY DISEASE; PREVALENCE; PRIORITY JOURNAL; SEXUAL BEHAVIOR; STATISTICAL ANALYSIS; UTERINE CERVICITIS;

ADULT; CERVICITIS; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; COMPARATIVE STUDY; COST-BENEFIT ANALYSIS; COSTS AND COST ANALYSIS; FEMALE; HUMAN; MASS SCREENING; ONTARIO; PREVALENCE; REGRESSION ANALYSIS; SENSITIVITY AND SPECIFICITY; SUPPORT, NON-U.S. GOV'T;

EID: 0026802232     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.1992.00400210067011     Document Type: Article

References (42)

1. Washington AE, Johnson RE, Sanders LL. Chlamydia trachomatis infections in the United States: what are they costing us? JAMA. 1986;257:2070-2072.
2. Holmes KK. Lower genital tract infections in women. In: Holmes KK, Mardh PA, Sparling PF, et al, eds. Sexually Transmitted Diseases. 2nd ed. New York, NY: McGraw-Hill International Book Co; 1990:527-545.
3. Paavonen J, Kiviat N, Brunham RC, et al. Prevalence and manifestations of endometritis among women with cervicitis. Am J Obstet Gynecol. 1985;152:280-286.
4. Jones RB, Mammel JB, Shepard MK, Fisher RR. Recovery of Chlamydia trachomatis from the endometrium of women at risk for chlamydial infection. Am J Obstet Gynecol. 1986;155:35-39.
5. Brunham RC, Maclean IW, Binns B, Peeling RW. Chlamydia trachomatis: its role in tubal infertility. J Infect Dis. 1985;152:1275-1282.
6. Sellors JW, Mahony JB, Chernesky MA, Rath DJ. Tubal factor infertility: an association with prior chlamydial infection and asymptomatic salpingitis. Fertil Steril. 1988;49:451-457.
7. Brunham RC, Rinns B, McDowell J, Paraskevas M. Chlamydia trachomatis infection in women with ectopic pregnancy. Obstet Gynecol. 1986;67:722-726.
8. Chow JM, Yonekura ML, Richwald GA, Greenland S, Sweet RL, Schachter J. The association between Chlamydia trachomatis and ectopic pregnancy. JAMA. 1990;263:3164-3167.
9. Centers for Disease Control. Pelvic inflammatory disease: guidelines for prevention and management and purified protein derivative (PPD)-tuberculin anergy and HIV infection: guidelines for anergy testing and management of anergic persons at risk of tuberculosis. MMWR. 1991;40:1-25.
10. Sellors J, Mahony J, Goldsmith C, et al. The accuracy of clinical findings and laparoscopy in pelvic inflammatory disease. Am J Obstet Gynecol. 1991;164:113-120.
11. Handsfield HH, Jasman LL, Roberts PL, Hanson VW, Kothenbeutel RL, Stamm WE. Criteria for selective screening for Chlamydia trachomatis in women attending family planning clinics. JAMA. 1986;255:1730-1734.
12. Johnson BA, Poses RM, Fortner CA, Meier FA, Dalton HP. Derivation and validation of a clinical diagnostic model for chlamydial cervical infection in university women. JAMA. 1990;264:3161-3165.
13. Sellors JW, Mahony JB, Jang D, et al. Comparison of cervical, urethral, and urine specimens for the detection of Chlamydia trachomatis in women. J Infect Dis. 1991;164:205-208.
14. Machin D, Campbell MJ. Statistical Tables for the Design of Clinical Trials. Boston, Mass: Blackwell Scientific Publications Inc; 1987:10-34.
15. Drummond MF, Stoddard GL, Torrance GW. Methods for the Economic Evaluation of Health Care Programmes. New York, NY: Oxford University Press Inc; 1987:74-111.
16. Begley CD, McGill L, Smith P. The incremental cost of screening, diagnosis, and treatment of gonorrhea and chlamydia in a family planning clinic. Sex Transm Dis. 1989;16:63-67.
17. Estany A, Todd M, Vasquez M, McLaren R. Early detection of genital chlamydial infection in women: an economic evaluation. Sex Transm Dis. 1989;16:21-27.
18. Phillips RS, Aronson MD, Taylor WC, Safran C. Should tests for Chlamydia trachomatis cervical infection be done during routine gynecologic visits? An analysis of the costs of alternative strategies. Ann Intern Med. 1987;107:188-194.
19. Nettleman MD, Jones RB. Cost-effectiveness of screening women at moderate risk for genital infections caused by Chlamydia trachomatis. JAMA. 1988;260:207-213.
20. Trachtenberg AI, Washington AE, Halldorson S. A cost-based decision analysis for chlamydia screening in California family planning clinics. Obstet Gynecol. 1988;71:101-108.
21. Gafni A, Torrance GW. Risk attitude and time preference in health. Manage Sci. 1984;30:440-451.
22. Birch S, Gafni A. Cost-effectiveness: utility analysis. Do current decision rules lead us to where we want to be? In: Working Paper Series, Centre for Health Economics and Policy Analysis. Hamilton, Ontario: Dept of Clinical Epidemiology and Biostatistics, McMaster University; 1991.
23. McCormack WM, Rosner B, McComb DE, Evrard JR, Zinner SH. Infection with Chlamydia trachomatis in female college students. Am J Epidemiol. 1985;121:107-115.
24. Phillips RS, Hanff PA, Holmes MD, Wertheimer A, Aronson MD. Chlamydia trachomatis cervical infection in women seeking routine gynecologic care: criteria for selective testing. Am J Med. 1989;86:515-520.
25. Winter L, Goldy AS, Baer C. Prevalence and epidemiologic correlates of Chlamydia trachomatis in rural and urban populations. Sex Transm Dis. 1990;17:30-36.
26. Harrison HR, Costin M, Meder JB, et al. Cervical Chlamydia trachomatis infection in university women: relationship to history, contraception, ectopy, and cervicitis. Am J Obstet Gynecol. 1985;153:244-251.
27. Magder LS, Harrison HR, Ehret JM, Anderson TS, Judson FN. Factors related to genital Chlamydia trachomatis and its diagnosis by culture in a sexually transmitted disease clinic. Am J Epidemiol. 1988;128:298-308.
28. Rosenthal GE, Landefeld CS. The relation of chlamydial infection of the cervix to time elapsed from the onset of menses. J Clin Epidemiol. 1990;43:15-20.
29. Remafedi G, Abdalian SE. Clinical predictors of Chlamydia trachomatis endocervicitis in adolescent women: looking for the right combination. AJDC. 1989;143:1437-1442.
30. Brunham RC, Paavonen J, Stevens CE, et al. Mucopurulent cervicitis: the ignored counterpart in women of urethritis in men. N Engl J Med. 1984;311:1-6.
31. Lindner LE, Geerling S, Nettum JA, Miller SL, Altman KH. Clinical characteristics of women with chlamydial cervicitis. J Reprod Med. 1988;33:684-690.
32. Moscicki B, Shafer MA, Millstein SG, Irwin CE, Schachter J. The use of endocervical Gram stains and mucopurulent cervicitis as predictors for Chlamydia trachomatis in female adolescents. Am J Obstet Gynecol. 1987;157:65-71.
33. Rahm VA, Odlind V, Gnarpe H. Chlamydia trachomatis among sexually active teenage girls: influence of sampling location and clinical signs on the detection rate. Genitourin Med. 1990;66:66-69.
34. Saltz GR, Linnemann CC Jr, Brookman RR, Rauh JL. Chlamydia trachomatis cervical infections in female adolescents. J Pediatr. 1981;98:981-985.
35. Schachter J, Stoner E, Moncada J. Screening for chlamydial infections in women attending family planning clinics: evaluation of presumptive indicators for therapy. West J Med. 1983;138:375-379.
36. Shafer MA, Vaughan E, Lipkin ES, Moscicki BA, Schachter J. Evaluation of fluorescein-conjugated monoclonal antibody test to detect Chlamydia trachomatis endocervical infections in adolescent girls. J Pediatr. 1986;108:779-783.
37. Hopwood J, Mallinson H, Agnew E. Chlamydia screening: should it be offered as a routine? a feasibility study in family planning clinics. Br J Fam Plan. 1990;16:59-67.
38. Washington AE, Gove S, Schachter J, Sweet RL. Oral contraceptives, Chlamydia trachomatis infection, and pelvic inflammatory disease: a word of caution about protection. JAMA. 1985;253:2246-2250.
39. Kellogg JA. Clinical and laboratory considerations of culture vs antigen assays for detection of Chlamydia trachomatis from genital specimens. Arch Pathol Lab Med. 1989;113:453-460.
40. Lipkin ES, Moncada JV, Shafer MA, Wilson TE, Schachter J. Comparison of monoclonal antibody staining and culture in diagnosing cervical chlamydial infection. J Clin Microbiol. 1986;23:114-117.
41. Baselski VS, McNeeley SG, Ryan G, Robison M. A comparison of nonculture-dependent methods for the detection of Chlamydia trachomatis infections in pregnant women. Obstet Gynecol. 1987;70:47-52.
42. Ripa T. Epidemiologic control of genital Chlamydia trachomatis infections. Scand J Infect Dis. 1990;69(suppl):157-167.